Manufacture

Ravi Nalliah explains his journey from biochemistry and molecular biology student, to chartered accountant, to supply chain CDMO founder.

Here we explore the challenges involved in ensuring CAR T cell therapies are delivered to patients safely and as quickly as possible.

It is time to rethink traditional approaches to biosafety.

It's time to vote for the grand winner of The Medicine Maker Innovation Awards.

If we learn more about drug–nutrient interactions, we may be on the path towards better medicines.

How can pharmaceutical packaging be adapted to meet patient and supply chain requirements?

How are reactor technologies supporting pharma companies?

How are digital technologies addressing supply chain challenges?

A synthetic system which mimics the compartmentalized nature of cells could help in the delivery of drugs.

Is the industry ready for continuous manufacturing?